Skip to main content
David R. Hillyard, MD
Medical Director: Molecular Infectious Diseases
Professor, University of Utah School of Medicine Specialties Medical microbiology Microbial genetics Education Medical Degree—Columbia University Residency—Pathology Chief Resident, St. Luke’s—Roosevelt Hospital Fellowship—Microbial Genetics, University of Utah School of Medicine Fellowship—Medical Microbiology, University of Utah School of Medicine Certification/Affiliations Research Interests Molecular Pathology and Genetics Hepatitis, HIV Awards National Science Foundation Scholarship (Genetics) Recent Publications Tolan NV, Horowitz GL, Graham CS, et al. New therapies for treating hepatitis C virus: impact on laboratory testing recommendations and clinical management . Clin Chem . 2017;63(12):1799-1805. Pyne MT, Mallory MA, Xie HB, et al. Sequencing of the hepatitis D virus RNA WHO international standard . J Clin Virol . 2017;90:52-56. Hayden RT, Sun Y, Tang L, et al. Progress in quantitative viral load testing: variability and impact of the WHO quantitative international standards . J Clin Microbiol . 2017;55(2):423-430. Mallory MA, Lucic D, Ebbert MT, et al. Evaluation of the Abbott RealTime HCV genotype plus RUO (PLUS) assay with reference to core and NS5B sequencing . J Clin Virol . 2017;90:26-31. Zhang Y, Sakthivel SK, Bramley A, et al. Serology enhances molecular diagnosis of respiratory virus infections other than influenza in children and adults hospitalized with community-acquired pneumonia . J Clin Microbiol . 2016;55(1):79-89. Fryer JF, Heath AB, Minor PD, et al. A collaborative study to establish the 1st WHO International Standard of human cytomegalovirus for nucleic acid amplification technology . Biological . 2016;44(4):242-251.